ARTICLE | Company News
Metasyn, Mallinckrodt Group Inc. deal
October 7, 1996 7:00 AM UTC
The companies agreed to develop and market MS-325, Metasyn's agent for imaging cardiovascular systems in magnetic resonance imaging. Metasyn will receive a $6 million license fee and share in the pro...